Expert Review of Clinical Immunology (ISSN 1744-666X) provides expert analysis and commentary regarding the performance of new therapeutic and diagnostic modalities in clinical immunology. Members of the International Editorial Advisory Panel of Expert Review of Clinical Immunology are the forefront of their area of expertise. This panel works with our dedicated editorial team to identify the most important and topical review themes and the corresponding expert(s) most appropriate to provide commentary and analysis. All articles are subject to rigorous peer-review, and the finished reviews provide an essential contribution to decision-making in clinical immunology. Articles focus on the following key areas:• Therapeutic overviews of specific immunologic disorders highlighting optimal therapy and prospects for new medicines• Performance and benefits of newly approved therapeutic agents• New diagnostic approaches• Screening and patient stratification• Pharmacoeconomic studies• New therapeutic indications for existing therapies• Adverse effects, occurrence and reduction• Prospects for medicines in late-stage trials approaching regulatory approval• Novel treatment strategies• Epidemiological studies• Commentary and comparison of treatment guidelines Topics include infection and immunity, inflammation, host defense mechanisms, congenital and acquired immunodeficiencies, anaphylaxis and allergy, systemic immune diseases, organ-specific inflammatory diseases, transplantation immunology, endocrinology and diabetes, cancer immunology, neuroimmunology and hematological diseases.
临床免疫学专家评论（ISSN 1744- 666 X）提供了关于临床免疫学中新的治疗和诊断模式的性能的专家分析和评论。《临床免疫学专家评论》国际编辑咨询小组的成员是他们专业领域的前沿。该专家组与我们专门的编辑团队合作，确定最重要和最热门的评论主题，以及最适合提供评论和分析的相应专家。所有文章都经过严格的同行评审，完成的评审为临床免疫学决策提供了重要贡献。文章集中在以下关键领域：·特定免疫疾病的治疗概述，强调最佳治疗和新药的前景·新批准的治疗药物的性能和益处·新的诊断方法·筛选和患者分层·药物经济学研究·现有疗法的新治疗适应症·不良反应、发生率和减少·接近监管批准的后期试验药物的前景·新的治疗策略·流行病学研究·治疗指南的评论和比较主题包括感染和免疫、炎症、宿主防御机制、先天性和获得性免疫缺陷、过敏反应和变态反应、全身免疫疾病、器官特异性炎症性疾病、移植免疫学、内分泌学和糖尿病、癌症免疫学、神经免疫学和血液学疾病。
Clinically-useful serum biomarkers for diagnosis and prognosis of sarcoidosis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1568240
From mother to baby: antenatal exposure to monoclonal antibody biologics
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1561282
An update on pathogenesis of psoriatic arthritis and potential therapeutic targets
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1627876
Overall and comparative safety of biologic and immunosuppressive therapy in inflammatory bowel diseases
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1646127
CD40 ligand deficiency: treatment strategies and novel therapeutic perspectives
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1573674
Sex and autoimmunity: proposed mechanisms of disease onset and severity
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1606714
Infusion-related reactions to rituximab: frequency, mechanisms and predictors
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1562905
Association of TNF, IL12, and IL23 gene polymorphisms and psoriatic arthritis: meta-analysis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1564039
New challenges in integrated diagnosis by imaging and osteo-immunology in bone lesions
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1561283
Topical agents for the treatment of atopic dermatitis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1564038
Infection risk in patients undergoing treatment for inflammatory arthritis: non-biologics versus biologics
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1705785
Predicting lymphoma development in patients with Sjögren’s syndrome
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1649596
Exercise-induced anaphylaxis: causes, consequences, and management recommendations
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1562904
Endotype-driven precision medicine in chronic rhinosinusitis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1679626
Managing immune dysregulation resulting from immune checkpoint inhibitors: impact of the ASCO guidelines and key take-homes for immunologists
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1559731
Autoantibodies to protein-arginine deiminase (PAD) 4 in rheumatoid arthritis: immunological and clinical significance, and potential for precision medicine
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1668778
Metabolic syndrome and systemic lupus erythematosus: the connection
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1620601
Periodontitis: a newly identified comorbidity in psoriasis and psoriatic arthritis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1700113
Epithelial physical barrier defects in chronic rhinosinusitis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1601556
Cytokines: the yin and yang of vitiligo pathogenesis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1550358
The long-awaited ‘pseudo-DFS pattern’
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1596801
Anti IL-17 in psoriasis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1679625
Obstructive lung diseases and risk of rheumatoid arthritis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1698293
Tofacitinib for the treatment of rheumatoid arthritis: an update
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1607298
Management of pregnant women with antiphospholipid antibodies
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1565995
Total threshold cytotoxicity of therapeutic antibodies for selective destruction of pathogenic memory T cells: implications for immunotherapy of autoimmune and allergenic disorders
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1617698
Biologic discontinuation strategies and outcomes in patients with rheumatoid arthritis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1686976
Biological therapy in the treatment of psoriatic arthritis: economic and epidemiological considerations
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1631798
What have recent advances in therapy taught us about severe asthma disease mechanisms?
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1672536
Just another crappy commentary: the future of fecal microbiota transplantation
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1656528
Novel and emerging treatments for Aicardi-Goutières syndrome
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1707663
B cells and atherosclerosis in systemic lupus erythematosus
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1571411
Biomarkers of skin and lung fibrosis in systemic sclerosis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1670062
B-cell depleting immunotherapies: therapeutic opportunities and toxicities
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1573672
Treatment of pemphigus vulgaris: part 2 – emerging therapies
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1672539
Protocols for drug allergy desensitization in children
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1698294
Allergen-induced asthma, chronic rhinosinusitis and transforming growth factor-β superfamily signaling: mechanisms and functional consequences
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1672538
The evaluation of neutropenia in common variable immune deficiency patients
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1677154
Thrombotic microangiopathy in adult-onset Still’s disease: the story is just beginning
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1682892
Screening children for eosinophilic esophagitis: allergic and other risk factors
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1579643
Canakinumab for the treatment of hyperimmunoglobulin D syndrome
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1571410
Current understanding and recent advances in myositis-specific and -associated autoantibodies detected in patients with dermatomyositis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1699059
Limits of traditional evidence-based medicine methodologies exemplified by the novel era in psoriatic arthritis drug development
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1580144
Clinical efficacy of sublingual immunotherapy tablets for allergic rhinitis is unlikely to be derived from in vitro allergen-release data
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1649597
Measuring and managing appearance anxiety in patients with systemic sclerosis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1573673
Deciphering the genotype and phenotype of hairy cell leukemia: clues for diagnosis and treatment
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1641405
The complexity of adverse event assessment and counseling for patients on biologic treatment
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1642749
Amifampridine for the treatment of Lambert-Eaton myasthenic syndrome
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1670061
SQ house dust mite sublingual immunotherapy for the treatment of adults with house dust mite-induced allergic rhinitis
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2020.1676731
The molecular immunology of human susceptibility to fungal diseases: lessons from single gene defects of immunity
来源期刊：Expert Review of Clinical ImmunologyDOI：10.1080/1744666X.2019.1584038
